Viewing Study NCT01703468


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2025-12-29 @ 8:58 PM
Study NCT ID: NCT01703468
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2012-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Sponsor: Roxane Laboratories
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module